Federal contract award
W91YTZ21C0006
BLOOD TESTING
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRCO EAST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.9M |
| Current contract value | $3.9M |
| Potential contract value / ceiling | $3.9M |
| Start date | Apr 1, 2021 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Jul 8, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 8, 2025 | P00017 | $-100.0K | KMW FY25 DEOB BLOOD TESTING MAHC |
| Mar 26, 2025 | P00016 | $-350.0K | KMW FY25 DECREASE MOORE |
| Feb 14, 2025 | P00015 | $-286.2K | KMW BMOD FY24 DEOB MOORE |
| Oct 31, 2024 | P00014 | $1.3M | KMW UMOD FUNDING BLOOD TESTING MOORE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.